Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mofegiline

Known as: 4-fluoro-beta-(fluoromethylene)benzenebutanamine, Benzenebutanamine, 4-fluoro-beta-(fluoromethylene)-, (E)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Mechanistic and structural studies have been carried out to investigate the molecular basis for the irreversible inhibition of… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 7
1996
1996
SummarySpecific inhibitors of monoamine oxidase type B (MAO-B) constitute a novel and expanding pharmacological class. At present… Expand
1995
1995
The safety, pharmacokinetics, and pharmacodynamics of single oral doses of up to 48 mg and daily (for 28 days) doses of up to 24… Expand
1994
1994
Mofegiline or MDL 72,974A ((E)-4-fluoro-beta-fluoromethylene benzene butanamine hydrochloride) is a selective enzyme-activated… Expand
1994
1994
The effects of monoamine oxidase B (MAO‐B) inhibition by mofegiline on the pharmacokinetics of p‐tyramine and its major… Expand
1994
1994
A sensitive and specific analytical method has been developed for the measurement of beta-phenylethylamine (PEA) in human plasma… Expand